Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Health Affairs (Project Hope)|October 7, 2024
Postapproval Innovation For Oncology Drugs And The Inflation Reduction ActHenry Grabowski, Joseph A DiMasi, Genia LongJournal of Medical Economics|February 29, 2024
Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction ActHenry Grabowski, Genia LongHealth Affairs (Project Hope)|February 4, 2015
The roles of patents and research and development incentives in biopharmaceutical innovationHenry G Grabowski, Joseph A DiMasi, Genia LongJournal of Medical Economics|December 11, 2013
Recent trends in brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard MortimerHealth Affairs (Project Hope)|September 13, 2006
The market for follow-on biologics: how will it evolve?Henry Grabowski, Iain Cockburn, Genia LongPharmacoeconomics|November 30, 2002
Returns on research and development for 1990s new drug introductionsHenry Grabowski, John Vernon, Joseph A DiMasiJournal of Medical Economics|April 12, 2016
Updated trends in US brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.Journal of Medical Economics|July 13, 2021
Continuing trends in U.S. brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.Pharmacoeconomics|November 30, 2002
The value of improving the productivity of the drug development process: faster times and better decisionsJoseph A DiMasiAmerican Journal of Therapeutics|September 1, 1996
A New Look At United States Drug Development and Approval TimesJoseph A. DiMasiPageof 5